TipRanks
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (TSE:ABT)
TSX:ABT
Canadian Market

Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (ABT) Ratios

3 Followers

Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged Ratios

TSE:ABT's free cash flow for Q3 2020 was $―. For the 2020 fiscal year, TSE:ABT's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Jun 20Jun 19Jun 18
Liquidity Ratios
Current Ratio
1.38- ―
Quick Ratio
0.97- ―
Cash Ratio
0.29- ―
Solvency Ratio
0.13- ―
Operating Cash Flow Ratio
0.56- ―
Short-Term Operating Cash Flow Coverage
3.30- ―
Net Current Asset Value
$ -32.94B$ -87.03M$ ―
Leverage Ratios
Debt-to-Assets Ratio
0.30- ―
Debt-to-Equity Ratio
0.64- ―
Debt-to-Capital Ratio
0.39- ―
Long-Term Debt-to-Capital Ratio
0.37- ―
Financial Leverage Ratio
2.14- ―
Debt Service Coverage Ratio
2.16- ―
Interest Coverage Ratio
12.45- ―
Debt to Market Cap
0.19- ―
Interest Debt Per Share
19.07- ―
Net Debt to EBITDA
2.77 -0.93 ―
Profitability Margins
Gross Profit Margin
56.80%-―
EBIT Margin
17.17%-―
EBITDA Margin
21.34%-―
Operating Profit Margin
17.03%-―
Pretax Profit Margin
16.12%-―
Net Profit Margin
11.65%-―
Continuous Operations Profit Margin
11.65%-―
Net Income Per EBT
72.23%-―
EBT Per EBIT
94.69%-―
Return on Assets (ROA)
4.97%8.17%―
Return on Equity (ROE)
10.52%-24.70%―
Return on Capital Employed (ROCE)
8.68%56.31%―
Return on Invested Capital (ROIC)
6.07%23.96%―
Return on Tangible Assets
9.56%8.24%―
Earnings Yield
3.11%0.00%―
Efficiency Ratios
Receivables Turnover
5.42- ―
Payables Turnover
4.20- ―
Inventory Turnover
2.75- ―
Fixed Asset Turnover
3.64- ―
Asset Turnover
0.43- ―
Working Capital Turnover Ratio
6.73- ―
Cash Conversion Cycle
113.10 7.00 ―
Days of Sales Outstanding
67.37 127.64 ―
Days of Inventory Outstanding
132.68 0.00 ―
Days of Payables Outstanding
86.96 120.64 ―
Operating Cycle
200.06 127.64 ―
Cash Flow Ratios
Operating Cash Flow Per Share
5.68- ―
Free Cash Flow Per Share
5.00- ―
CapEx Per Share
0.68- ―
Free Cash Flow to Operating Cash Flow
0.88- ―
Dividend Paid and CapEx Coverage Ratio
1.82- ―
Capital Expenditure Coverage Ratio
8.36- ―
Operating Cash Flow Coverage Ratio
0.30- ―
Operating Cash Flow to Sales Ratio
0.21- ―
Free Cash Flow Yield
5.03%0.00%―
Valuation Ratios
Price-to-Earnings (P/E) Ratio
32.19- ―
Price-to-Sales (P/S) Ratio
3.72- ―
Price-to-Book (P/B) Ratio
3.41- ―
Price-to-Free Cash Flow (P/FCF) Ratio
19.86- ―
Price-to-Operating Cash Flow Ratio
17.61- ―
Price-to-Earnings Growth (PEG) Ratio
-0.52- ―
Enterprise Value Multiple
20.19- ―
Enterprise Value
200.72B 0.00 ―
EV to EBITDA
20.19 0.00 ―
EV to Sales
4.31 0.00 ―
EV to Free Cash Flow
23.02 0.00 ―
EV to Operating Cash Flow
20.26 0.00 ―
Tangible Book Value Per Share
-0.40- ―
Shareholders’ Equity Per Share
29.32- ―
Tax and Other Ratios
Effective Tax Rate
0.28- ―
Revenue Per Share
26.73- ―
Net Income Per Share
3.11- ―
Tax Burden
0.72 0.70 ―
Interest Burden
0.94 0.96 ―
Research & Development to Revenue
0.07 0.17 ―
SG&A to Revenue
0.29 0.20 ―
Stock-Based Compensation to Revenue
0.02 0.06 ―
Income Quality
1.83 2.35 ―
Currency in USD